BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells

Inflammatory breast cancer (IBC) is a highly metastatic and rare type of breast cancer, accounting for 2–6% of newly diagnosed breast cancer cases each year. The highly metastatic nature of IBC cells remains poorly understood. Here we describe our recent data regarding the ability of IBC cells to ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchheit, Cassandra L, Schafer, Zachary T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845165/
https://www.ncbi.nlm.nih.gov/pubmed/27308529
http://dx.doi.org/10.1080/23723556.2015.1011474
_version_ 1782428893219651584
author Buchheit, Cassandra L
Schafer, Zachary T
author_facet Buchheit, Cassandra L
Schafer, Zachary T
author_sort Buchheit, Cassandra L
collection PubMed
description Inflammatory breast cancer (IBC) is a highly metastatic and rare type of breast cancer, accounting for 2–6% of newly diagnosed breast cancer cases each year. The highly metastatic nature of IBC cells remains poorly understood. Here we describe our recent data regarding the ability of IBC cells to overcome anoikis.
format Online
Article
Text
id pubmed-4845165
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-48451652016-06-15 BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells Buchheit, Cassandra L Schafer, Zachary T Mol Cell Oncol Author's View Inflammatory breast cancer (IBC) is a highly metastatic and rare type of breast cancer, accounting for 2–6% of newly diagnosed breast cancer cases each year. The highly metastatic nature of IBC cells remains poorly understood. Here we describe our recent data regarding the ability of IBC cells to overcome anoikis. Taylor & Francis 2015-02-03 /pmc/articles/PMC4845165/ /pubmed/27308529 http://dx.doi.org/10.1080/23723556.2015.1011474 Text en © 2016 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Author's View
Buchheit, Cassandra L
Schafer, Zachary T
BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title_full BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title_fullStr BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title_full_unstemmed BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title_short BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells
title_sort bim-el localization: the key to understanding anoikis resistance in inflammatory breast cancer cells
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845165/
https://www.ncbi.nlm.nih.gov/pubmed/27308529
http://dx.doi.org/10.1080/23723556.2015.1011474
work_keys_str_mv AT buchheitcassandral bimellocalizationthekeytounderstandinganoikisresistanceininflammatorybreastcancercells
AT schaferzacharyt bimellocalizationthekeytounderstandinganoikisresistanceininflammatorybreastcancercells

Ejemplares similares